The eagerly awaited 2025 ACC/AHA ACS guidelines were released yesterday! Congrats to Sunil V. Rao Michelle O'Donoghue and all the co-authors 1/ Here are some of my takeways

8/ For intermediate or high-risk NSTE-ACS invasive management recommended, if low risk NSTE-ACS invasive or selective invasive recommended.

Mavacamten was associated with reductions in biomarkers of cardiac wall stress and injury, with no sustained reductions in LVEF observed in patients with HFpEF and LVEF of 60% or greater. ja.ma/4k1namN

Aortic Dissection‼️ H/T: Qasim Al Abri #Echofirst #POCUS #CardioEd #ENARM #ultrasound #MedEd #Cardiology #MedTwitter #CardioTwitter #FOAMed #FOAMcc Matters of the Heart 🫀 Echofirst Bot #FOAMcc #ICU

This is a great episode. One addition to below graphic: Below refers to narrow complex tachycardia but should also mention REGULAR. If irregular - i.e. maybe Afib - adenosine is generally not recommended (Won't fix the issue, contraindicated in pre-excitation)

1/ 🚨 The #Impella devices are percutaneous mechanical circulatory support systems used in high-risk #PCI & #cardiogenicshock. Here’s a breakdown of the different types and their clinical indications. 🏥💔👇

🚨 ECG Pearl: Spodick’s Sign 🚨 A subtle but valuable clue in acute pericarditis: a downsloping TP segment seen best in lead II and precordial leads. 🫀 A thread on its significance, specificity, and pitfalls. 🧵🔽

Consultant 1: Admit to ENT Consultant 2: Admit to Gen Surg Me: How about this…

Life Course Approach for Managing Familial Hypercholesterolemia | Journal of the American Heart Association ahajournals.org/doi/10.1161/JA… Living with FH not so bad anymore, as long as we find it and treat it! FH Europe Foundation Fundación HF International Atherosclerosis Society (IAS) European Atherosclerosis Society

💡Can people with obesity reach a “normal” weight through diet & lifestyle alone? A massive UK study of 177,000+ adults says… not easily. 📉 Over 9 years (no surgery involved): For those with class 1 obesity (BMI 30–34.9): 🔹Men: 1 in 210 reached normal weight 🔹Women: 1 in 124

Lpa screening is not only cost effective but may save money! Zanfina Ademi showing amazing new data! #LPaGlobalSummit FH Europe Foundation International Atherosclerosis Society (IAS) World Heart Federation European Atherosclerosis Society @GlobaHeartHub #prevention

Obesity is strongly associated with the incidence of 📈 HTN, T2DM, Dyslipidemia 💔 HF, Atrial Fibrillation, CKD 🫁 PE, DVT, OSA, Asthma 🦵 Gout, OA 🍽️ MASLD, GERD, Biliary Disease Fantastic article by our superstar Jackie Yao NEJM NEJM Evidence Beverly G. Tchang, MD Roger Blumenthal

One of the most important trials at American College of Cardiology #ACC25 ! Compared fluid restriction to liberal approach in #HeartFailure. Why? This affects individuals w/HF EVERY DAY! ✨No benefit of Fluid Restriction ✨No HARM for liberal fluid intake ✨Improved QOL in liberal fluid intake

A BIG moment just dropped: The design of the Lp(a)HORIZON trial is now published. sciencedirect.com/science/articl… Brief summary: 1- 8,323 patients 2- median Lp(a) level of 108 mg/dL and 236 nmol/L - higher than likely anticipated 3- 79% of patients were ≥90 mg/dL - higher than

🔶Small Vessels, Big Impact!🔶 Check out this new infographic on the pathophysiology, diagnosis and treatment of Coronary Microvascular Disease 🫀 #HeartHealth #CMD Thank you to CardioNerds, Rachel Goodman and Amit Goyal MD MAS for their review!

#CardioNuggets : 🫀What is PAPI? PA Pulsatility Index = (PASP - PADP) / RAP A quick invasive marker of RV function! It reflects the RV’s ability to generate pulsatile flow vs its filling pressure. So PAPI assesses the RV’s ability to generate pulsatile flow relative to its

#TriviaTuesday Did you know that the risk of stroke in AFib is similar between AFib in the community, during acute illness, and during non-cardiac surgery? Take a listen to our #GrayMatters episode to learn more ⤵️ coreimpodcast.com/2023/01/18/dia…

🚨BREAKING: Lilly’s oral GLP-1, orforglipron, hits its primary endpoint in the Phase 3 ACHIEVE-1 trial for type 2 diabetes. 🔸A1C↓ by 1.3–1.6% 🔸Weight loss: up to 16 lbs (7.9%) 🔸65%+ hit A1C ≤6.5% Once-daily, oral small molecule GLP-1—no food/water restrictions Safety

“Only one in five patients on high-intensity statin monotherapy get to goal, so the need for combination therapy is inevitable,” Prof Kausik Ray FMedSci told TCTMD. Learn more about the new #JACC study: bit.ly/4lWOwLO

Understand the best practices for BP measurement for #hypertension patients with this infographic. 👇 Access the infographic, patient case quizzes & more 🆓 education w/ ACC's online course: bit.ly/4dUOal5 #ACCEd #WorldHypertensionDay #HighBloodPressureMonth #cvPrev